Publications
The ALIFE2 trial results are published here:
- Siobhan Quenby, Katie Booth, Louise Hiller, Arri Coomarasamy, Paulien G de Jong, Eva N Hamulyák, Luuk J Scheres, Thijs F van Haaps, Lauren Ewington, Shreeya Tewary, Mariëtte Goddijn, Saskia Middeldorp, for the ALIFE2 Block Writing Committee and ALIFE2 Investigators, Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial, The Lancet, (June 2023) DOI: https://doi.org/10.1016/S0140-6736(23)00693-1
- You can also read this news article, published on the Tommy's website, which describes the findings.
Previous ALIFE2 Publications:
- Eva N. Hamulyák, Paulien G. de Jong, Luuk J.J. Scheres, Lauren J. Ewington, Saskia Middeldorp, Siobhan Quenby, Mariëtte Goddijn, Progress of the ALIFE2 study: A dynamic road towards more evidence, Thrombosis Research, Volume 190 (2020) Pages 39-44 https://doi.org/10.1016/j.thromres.2020.03.015
- de Jong, P.G., Quenby, S., Bloemenkamp, K.W. et al. ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial. Trials 16, 208 (2015). https://doi.org/10.1186/s13063-015-0719-9
